LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article: Imaging prostate cancer: a multidisciplinary perspective.

    Hricak, Hedvig / Choyke, Peter L / Eberhardt, Steven C / Leibel, Steven A / Scardino, Peter T

    Radiology

    2007  Volume 243, Issue 1, Page(s) 28–53

    Abstract: The major goal for prostate cancer imaging in the next decade is more accurate disease ... on the optimal role of modern imaging in prostate cancer detection, staging, treatment planning, and follow-up. ... exists regarding the use of imaging for evaluating primary prostate cancers. Ultrasonography is mainly ...

    Abstract The major goal for prostate cancer imaging in the next decade is more accurate disease characterization through the synthesis of anatomic, functional, and molecular imaging information. No consensus exists regarding the use of imaging for evaluating primary prostate cancers. Ultrasonography is mainly used for biopsy guidance and brachytherapy seed placement. Endorectal magnetic resonance (MR) imaging is helpful for evaluating local tumor extent, and MR spectroscopic imaging can improve this evaluation while providing information about tumor aggressiveness. MR imaging with superparamagnetic nanoparticles has high sensitivity and specificity in depicting lymph node metastases, but guidelines have not yet been developed for its use, which remains restricted to the research setting. Computed tomography (CT) is reserved for the evaluation of advanced disease. The use of combined positron emission tomography/CT is limited in the assessment of primary disease but is gaining acceptance in prostate cancer treatment follow-up. Evidence-based guidelines for the use of imaging in assessing the risk of distant spread of prostate cancer are available. Radionuclide bone scanning and CT supplement clinical and biochemical evaluation (prostate-specific antigen [PSA], prostatic acid phosphate) for suspected metastasis to bones and lymph nodes. Guidelines for the use of bone scanning (in patients with PSA level > 10 ng/mL) and CT (in patients with PSA level > 20 ng/mL) have been published and are in clinical use. Nevertheless, changes in practice patterns have been slow. This review presents a multidisciplinary perspective on the optimal role of modern imaging in prostate cancer detection, staging, treatment planning, and follow-up.
    MeSH term(s) Bone and Bones/diagnostic imaging ; Humans ; Magnetic Resonance Imaging/methods ; Magnetic Resonance Spectroscopy/methods ; Male ; Positron-Emission Tomography ; Prostatic Neoplasms/diagnosis ; Radiography/methods ; Tomography, X-Ray Computed/methods ; Ultrasonography/methods
    Language English
    Publishing date 2007-04
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80324-8
    ISSN 1527-1315 ; 0033-8419
    ISSN (online) 1527-1315
    ISSN 0033-8419
    DOI 10.1148/radiol.2431030580
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: The future of molecular and functional imaging in prostate cancer.

    Renard-Penna, Raphaële / Gauthé, Mathieu

    Archivos espanoles de urologia

    2019  Volume 72, Issue 2, Page(s) 150–156

    Abstract: ... for the staging and recurrence staging of prostate cancer.This review presents a multidisciplinary perspective ... of the role of prostate MRI and molecular imaging in prostate cancer. ... The major goal of prostate cancer imaging in the next decade will be more accurate disease ...

    Title translation El futuro de las pruebas de imagen moleculares y funcionales en cáncer de próstata.
    Abstract The major goal of prostate cancer imaging in the next decade will be more accurate disease diagnostic, characterization and staging through the synthesisof anatomic, functional and molecular imaging.Changes are happening regarding the use of prostate MRI for evaluating primary prostate cancer and PET CT for the staging and recurrence staging of prostate cancer.This review presents a multidisciplinary perspective of the role of prostate MRI and molecular imaging in prostate cancer.
    MeSH term(s) Humans ; Magnetic Resonance Imaging ; Male ; Molecular Imaging ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Positron Emission Tomography Computed Tomography ; Positron-Emission Tomography ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/genetics
    Language English
    Publishing date 2019-03-07
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 211673-x
    ISSN 0004-0614
    ISSN 0004-0614
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Consensus on molecular imaging and theranostics in prostate cancer.

    Fanti, Stefano / Minozzi, Silvia / Antoch, Gerald / Banks, Ian / Briganti, Alberto / Carrio, Ignasi / Chiti, Arturo / Clarke, Noel / Eiber, Matthias / De Bono, Johann / Fizazi, Karim / Gillessen, Silke / Gledhill, Sam / Haberkorn, Uwe / Herrmann, Ken / Hicks, Rodney J / Lecouvet, Frederic / Montironi, Rodolfo / Ost, Piet /
    O'Sullivan, Joe M / Padhani, Anwar R / Schalken, Jack A / Scher, Howard I / Tombal, Bertrand / van Moorselaar, R Jeroen A / Van Poppel, Heindrik / Vargas, Hebert Alberto / Walz, Jochen / Weber, Wolfgang A / Wester, Hans-Jürgen / Oyen, Wim J G

    The Lancet. Oncology

    2018  Volume 19, Issue 12, Page(s) e696–e708

    Abstract: ... a balanced perspective on available data and clinical experience of imaging in prostate cancer, which had ... Rapid developments in imaging and treatment with radiopharmaceuticals targeting prostate cancer ... prostate cancer-targeted PET are frequently suggested, but the specific contexts in which these methods affect ...

    Abstract Rapid developments in imaging and treatment with radiopharmaceuticals targeting prostate cancer pose issues for the development of guidelines for their appropriate use. To tackle this problem, international experts representing medical oncologists, urologists, radiation oncologists, radiologists, and nuclear medicine specialists convened at the European Association of Nuclear Medicine Focus 1 meeting to deliver a balanced perspective on available data and clinical experience of imaging in prostate cancer, which had been supported by a systematic review of the literature and a modified Delphi process. Relevant conclusions included the following: diphosphonate bone scanning and contrast-enhanced CT are mentioned but rarely recommended for most patients in clinical guidelines; MRI (whole-body or multiparametric) and prostate cancer-targeted PET are frequently suggested, but the specific contexts in which these methods affect practice are not established; sodium fluoride-18 for PET-CT bone scanning is not widely advocated, whereas gallium-68 or fluorine-18 prostate-specific membrane antigen gain acceptance; and, palliative treatment with bone targeting radiopharmaceuticals (rhenium-186, samarium-153, or strontium-89) have largely been replaced by radium-223 on the basis of the survival benefit that was reported in prospective trials, and by other systemic therapies with proven survival benefits. Although the advances in MRI and PET-CT have improved the accuracy of imaging, the effects of these new methods on clinical outcomes remains to be established. Improved communication between imagers and clinicians and more multidisciplinary input in clinical trial design are essential to encourage imaging insights into clinical decision making.
    MeSH term(s) Biomarkers, Tumor/genetics ; Consensus ; Delphi Technique ; Humans ; Male ; Molecular Imaging/standards ; Predictive Value of Tests ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/therapy ; Theranostic Nanomedicine/standards ; Treatment Outcome
    Chemical Substances Biomarkers, Tumor
    Language English
    Publishing date 2018-12-03
    Publishing country England
    Document type Consensus Development Conference ; Journal Article ; Practice Guideline ; Research Support, Non-U.S. Gov't ; Systematic Review
    ZDB-ID 2049730-1
    ISSN 1474-5488 ; 1470-2045
    ISSN (online) 1474-5488
    ISSN 1470-2045
    DOI 10.1016/S1470-2045(18)30604-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Imaging in prostate cancer staging: present role and future perspectives.

    Pinto, Francesco / Totaro, Angelo / Palermo, Giuseppe / Calarco, Alessandro / Sacco, Emilio / D'Addessi, Alessandro / Racioppi, Marco / Valentini, AnnaLia / Gui, Benedetta / Bassi, PierFrancesco

    Urologia internationalis

    2012  Volume 88, Issue 2, Page(s) 125–136

    Abstract: ... of prostate cancer imaging in the next decade will be more accurate disease characterization through the synthesis ... strategy. No consensus exists regarding the use of imaging for evaluating primary prostate cancer ... This review presents a multidisciplinary perspective on the role of conventional and functional imaging ...

    Abstract Despite recent improvements in detection and treatment, prostate cancer continues to be the most common malignancy and the second leading cause of cancer-related mortality. Thus, although survival rate continues to improve, prostate cancer remains a compelling medical health problem. The major goal of prostate cancer imaging in the next decade will be more accurate disease characterization through the synthesis of anatomic, functional, and molecular imaging information in order to plan the most appropriate therapeutic strategy. No consensus exists regarding the use of imaging for evaluating primary prostate cancer. However, conventional and functional imaging are expanding their role in detection and local staging and, moreover, functional imaging is becoming of great importance in oncologic management and monitoring of therapy response. This review presents a multidisciplinary perspective on the role of conventional and functional imaging methods in prostate cancer staging.
    MeSH term(s) Bone Neoplasms/secondary ; Diagnostic Imaging/methods ; Diffusion Magnetic Resonance Imaging ; Evidence-Based Medicine ; Humans ; Magnetic Resonance Spectroscopy ; Male ; Neoplasm Invasiveness ; Neoplasm Staging/methods ; Positron-Emission Tomography ; Predictive Value of Tests ; Prognosis ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/pathology ; Tomography, X-Ray Computed ; Ultrasonography
    Language English
    Publishing date 2012
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 204045-1
    ISSN 1423-0399 ; 0042-1138
    ISSN (online) 1423-0399
    ISSN 0042-1138
    DOI 10.1159/000335205
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Imaging in Prostate Cancer Staging: Present Role and Future Perspectives

    Pinto, Francesco / Totaro, Angelo / Palermo, Giuseppe / Calarco, Alessandro / Sacco, Emilio / D’Addessi, Alessandro / Racioppi, Marco / Valentini, AnnaLia / Gui, Benedetta / Bassi, PierFrancesco

    Urologia Internationalis

    2012  Volume 88, Issue 2, Page(s) 125–136

    Abstract: ... of prostate cancer imaging in the next decade will be more accurate disease characterization through the synthesis ... strategy. No consensus exists regarding the use of imaging for evaluating primary prostate cancer ... This review presents a multidisciplinary perspective on the role of conventional and functional imaging ...

    Institution Department of Urology and Department of Bioimaging and Radiological Sciences, Catholic University of the Sacred Heart, Rome, Italy
    Abstract Despite recent improvements in detection and treatment, prostate cancer continues to be the most common malignancy and the second leading cause of cancer-related mortality. Thus, although survival rate continues to improve, prostate cancer remains a compelling medical health problem. The major goal of prostate cancer imaging in the next decade will be more accurate disease characterization through the synthesis of anatomic, functional, and molecular imaging information in order to plan the most appropriate therapeutic strategy. No consensus exists regarding the use of imaging for evaluating primary prostate cancer. However, conventional and functional imaging are expanding their role in detection and local staging and, moreover, functional imaging is becoming of great importance in oncologic management and monitoring of therapy response. This review presents a multidisciplinary perspective on the role of conventional and functional imaging methods in prostate cancer staging.
    Keywords Prostate cancer ; Staging ; MRI ; Diffusion-weighted MRI ; Prostate ultrasonography imaging ; Positron emission tomography ; Dynamic contrast-enhanced MRI ; Magnetic resonance spectroscopy
    Language English
    Publishing date 2012-01-27
    Publisher S. Karger AG
    Publishing place Basel, Switzerland
    Document type Article
    Note Review
    ZDB-ID 204045-1
    ISSN 1423-0399 ; 0042-1138
    ISSN (online) 1423-0399
    ISSN 0042-1138
    DOI 10.1159/000335205
    Database Karger publisher's database

    More links

    Kategorien

  6. Article ; Online: Prostate MRI and image quality: The urologist's perspective.

    Khan, Amir / Moore, Caroline M / Minhaj Siddiqui, M

    European journal of radiology

    2023  Volume 170, Page(s) 111255

    Abstract: The development of different imaging modalities of the prostate has significantly improved tumor ... stratification, and staging of clinically significant prostate cancer, PCa. As a result, mp-MRI of the prostate ... approach is crucial in the diagnosis and management of prostate cancer and mp-MRI plays a fundamental role ...

    Abstract The development of different imaging modalities of the prostate has significantly improved tumor detection, patient risk stratification, and quality of care.Among these, multiparametric magnetic resonance imaging (mp-MRI) has emerged as the most sensitive tool.It is useful in the diagnosis, localization, risk stratification, and staging of clinically significant prostate cancer, PCa. As a result, mp-MRI of the prostate is recommended as the initial diagnostic test for men with suspected PCa. A multidisciplinary approach is crucial in the diagnosis and management of prostate cancer and mp-MRI plays a fundamental role in this scenario.While many aspects of image quality certainly fall within the purview of radiology, it is important to recognize that urologists must also be attentive to imaging quality when utilizing mp-MRI to facilitate PCa management. We present our viewpoint as urologists on how image quality impacts the management of men diagnosed with PCa andattempt to identify the factors that impact mp-MRI image quality, consequences of poor image quality, and finally suggestions for improvements.
    MeSH term(s) Male ; Humans ; Prostate/diagnostic imaging ; Prostate/pathology ; Urologists ; Image-Guided Biopsy/methods ; Magnetic Resonance Imaging/methods ; Prostatic Neoplasms/pathology
    Language English
    Publishing date 2023-12-09
    Publishing country Ireland
    Document type Editorial
    ZDB-ID 138815-0
    ISSN 1872-7727 ; 0720-048X
    ISSN (online) 1872-7727
    ISSN 0720-048X
    DOI 10.1016/j.ejrad.2023.111255
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top